Data Monetization in Healthcare Market Size & Growth Forecast 2027–2036, By Segments (Method, End-user, Organization Size), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Data Monetization in Healthcare Market size was valued at USD 805.21 million in 2026 and is projected to grow at a 21.19% CAGR from 2027 to 2036, attaining USD 5.5 billion by 2036. The industry revenue for 2027 is estimated at USD 948.86 million.
Get more details on this report
Request Free Sample ReportData Monetization in Healthcare Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 34.13% share supported by mature digital health infrastructure, widespread EHR adoption, and established healthcare IT ecosystems enabling large-scale clinical and claims data monetization.
- Asia Pacific expands at 21.06% CAGR driven by rapid healthcare digitization, rising data volumes, expanding hospital networks, and modernization efforts enabling monetizable healthcare analytics ecosystems.
Segment Momentum
- Analytics-enabled Platform as a Service led the market with a 41.23% share in 2026 by combining scalable infrastructure and analytics capabilities that help healthcare organizations monetize data more efficiently.
- Medical technology companies are growing fastest as connected devices and digital healthcare tools generate valuable data that can be converted into insight-driven services, monitoring solutions, and recurring revenue opportunities.
Market Expansion Drivers
- Expanding EHR adoption and healthcare digitization enabling large-scale clinical data monetization.
- Rising adoption of AI and advanced analytics platforms transforming healthcare data into revenue assets.
- Growing pharmaceutical demand for real-world evidence accelerating healthcare data commercialization.
Leading Market Participants
- Major players in the data monetization in healthcare market include Oracle Corporation (United States), Microsoft Corporation (United States), Google LLC (United States), IQVIA Inc. (United States), Optum, Inc. (United States), Palantir Technologies Inc. (United States), SAS Institute Inc. (United States), Snowflake Inc. (United States), Health Catalyst, Inc. (United States), Flatiron Health, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 805.21 million
- 2027 Estimated Market Size: USD 948.86 million.
- Projected Market Size: USD 5.5 billion by 2036
- Growth Forecast: 21.19% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Analytics-enabled Platform as a Service (Method) | Pharmaceutical and Biotechnology Companies (End-user) | Large Enterprises (Organization Size)
- Emerging Opportunity Segment: Embedded Analytics (Method) | Medical Technology Companies (End-user) | Small & Medium Enterprises (SMEs) (Organization Size)
Market Growth Drivers and Industry Trends
Expanding EHR adoption and healthcare digitization enabling large-scale clinical data monetization
The data monetization in healthcare market is gaining momentum as the widespread adoption of electronic health records (EHRs) creates larger and more structured repositories of clinical information. Digitized patient records can provide valuable insights for healthcare providers, research organizations, pharmaceutical developers, and other authorized stakeholders when data is appropriately aggregated, governed, and protected. The transition from paper-based processes to interoperable digital systems also improves the availability and usability of clinical information for research, operational planning, population health analysis, and service optimization. As healthcare organizations accumulate increasingly comprehensive datasets, opportunities to derive commercial value from appropriately managed information are expanding.
Rising adoption of AI and advanced analytics platforms transforming healthcare data into revenue assets
Artificial intelligence and advanced analytics are increasing the commercial value of healthcare information by enabling organizations to identify patterns, generate predictive insights, and extract actionable intelligence from complex datasets. Within the data monetization in healthcare market, AI-based platforms can help transform fragmented clinical, operational, and patient data into analytical assets that support research, personalized care, resource planning, and decision-making. Machine learning can also improve the identification of relevant data relationships that may be difficult to detect through conventional analysis, making healthcare datasets more useful for authorized commercial applications. The integration of analytics into healthcare data infrastructure is consequently creating new pathways for organizations to generate value from information while maintaining appropriate governance controls.
Growing pharmaceutical demand for real-world evidence accelerating healthcare data commercialization
Pharmaceutical companies are increasingly seeking real-world evidence to understand treatment effectiveness, patient outcomes, healthcare utilization, and treatment patterns beyond controlled clinical trial environments. This demand is strengthening the data monetization in healthcare market by increasing the value of de-identified and appropriately governed clinical datasets that can support drug development, post-market evaluation, and evidence generation. Real-world data from healthcare records and other sources can help researchers examine how therapies perform across broader patient populations and different care settings, providing insights that complement traditional clinical research. The need for timely evidence to support therapeutic evaluation and healthcare decision-making is encouraging greater collaboration between data holders and pharmaceutical stakeholders.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding EHR adoption and healthcare digitization enabling large-scale clinical data monetization | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Rising adoption of AI and advanced analytics platforms transforming healthcare data into revenue assets | 1.90% | High | North America, Europe | High | Mid Term |
| Growing pharmaceutical demand for real-world evidence accelerating healthcare data commercialization | 1.60% | High | Global | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
Holding the largest share of the data monetization in healthcare market, North America accounted for 34.13% share in 2026, supported by mature digital health ecosystems, widespread adoption of electronic health records, and strong healthcare data infrastructure. The region benefits from sophisticated analytics capabilities, established data governance frameworks, and growing demand for actionable insights across healthcare delivery, clinical research, payer operations, and population health management. Increasing emphasis on value-based care and operational efficiency is also encouraging healthcare organizations to convert large volumes of clinical and administrative data into commercially and strategically useful assets.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing regional market, driven by expanding healthcare digitization, rising investments in health information infrastructure, and increasing adoption of cloud-based analytics and artificial intelligence across healthcare systems. Growing healthcare demand, broader use of digital patient platforms, and efforts to modernize fragmented data environments are creating new opportunities for data-driven business models. At the same time, evolving data privacy regulations and greater attention to interoperability are encouraging healthcare stakeholders to establish more structured approaches to data access, governance, and monetization.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Privacy-Centered Data UtilizationGermany prioritizes healthcare data monetization models that align with stringent privacy requirements and trusted data governance. The market increasingly supports structured data collaboration across hospitals, research institutions, and digital health providers to unlock value without compromising regulatory compliance.
France 🇫🇷
Public Health Data NetworksFrance supports healthcare data monetization through structured health information platforms that facilitate research and evidence generation. The country increasingly encourages responsible data access models that create commercial opportunities while maintaining patient confidentiality and governance standards.
Italy 🇮🇹
Integrated Clinical Data AccessItaly strengthens healthcare data monetization by improving digital connectivity among hospitals, healthcare providers, and research organizations. Commercial priorities increasingly focus on standardized health records that support analytics, clinical research, and value-added healthcare services.
Japan 🇯🇵
Research Data CollaborationJapan advances healthcare data monetization through integrated clinical databases that strengthen pharmaceutical research, precision medicine, and healthcare innovation. Organizations increasingly focus on standardized data management to improve the commercial utility of high-quality healthcare information.
South Korea 🇰🇷
AI-Enabled Health AnalyticsSouth Korea leverages digital healthcare infrastructure to expand monetization opportunities for medical data across AI development and clinical analytics. The market emphasizes secure data integration that enables collaboration between hospitals, technology developers, and healthcare innovators.
United States 🇺🇸
Value-Driven Data ExchangeThe U.S. data monetization in healthcare market emphasizes secure commercialization of clinical, claims, and real-world data through partnerships between healthcare providers, technology firms, and life sciences companies. Organizations increasingly invest in interoperable platforms that enable compliant data sharing while supporting research and operational decision-making.
Segment Leadership and Growth Trends
Data Monetization in Healthcare Market Share (%), by Method, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMethod Segment Analysis: Analytics-enabled Platform as a Service (Largest Segment) vs Embedded Analytics (Fastest-Growing Segment)
Analytics-enabled platform as a service segment dominated the data monetization in healthcare market in 2026, accounting for a 41.23% share. Its leading position is supported by healthcare organizations' growing need for scalable platforms that can consolidate, analyze, and operationalize data without requiring extensive internal infrastructure. These platforms enable organizations to transform fragmented healthcare information into actionable insights for operational improvement, research, population management, and commercial decision-making. Increasing adoption of cloud-based technologies and demand for flexible data environments are further supporting the use of analytics-enabled platforms as healthcare providers and other stakeholders seek more efficient ways to extract value from growing volumes of data.
Embedded analytics is projected to be the fastest-growing method as healthcare organizations increasingly seek to integrate data-driven insights directly into the applications and workflows used by professionals. Embedding analytical capabilities into existing systems can reduce the need to move between separate tools while enabling more immediate access to relevant information during operational and clinical processes. The broader shift toward real-time decision support, workflow automation, and user-centric digital healthcare solutions is creating favorable conditions for embedded analytics, particularly as organizations look to make data utilization a routine part of everyday operations.
End-user Segment Analysis: Pharmaceutical and Biotechnology Companies (Largest Segment) vs Medical Technology Companies (Fastest-Growing Segment)
Pharmaceutical and biotechnology companies held the largest share of the data monetization in healthcare market in 2026, accounting for a 41.98% share. These organizations generate and utilize extensive datasets across drug discovery, clinical development, real-world evidence, patient outcomes, and commercial activities, creating substantial opportunities to derive economic value from healthcare information. The growing importance of data-driven research and evidence generation is encouraging pharmaceutical and biotechnology organizations to invest in analytical capabilities that can convert complex datasets into insights for research, development, and strategic decision-making. Increasing emphasis on precision medicine and data-supported healthcare innovation further strengthens this segment's demand for monetization solutions.
Medical technology companies are expected to be the fastest-growing end-user segment as manufacturers increasingly incorporate connected technologies, digital platforms, and data-enabled capabilities into medical devices and healthcare solutions. The resulting expansion of device-generated and usage-related information creates new opportunities to generate value through analytics, service models, and data-driven offerings. Greater integration of digital health technologies with medical devices is also encouraging these companies to move beyond traditional product-based models toward solutions that leverage data to improve performance, support users, and create additional commercial value.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Method | Data as a Service, Insight as a Service, Analytics-enabled Platform as a Service, Embedded Analytics | Analytics-enabled Platform as a Service | Embedded Analytics |
| End-user | Pharmaceutical and Biotechnology Companies, Healthcare Players, Medical Technology Companies, Others | Pharmaceutical and Biotechnology Companies | Medical Technology Companies |
| Organization Size | Large Enterprises, Small & Medium Enterprises (SMEs) | Large Enterprises | Small & Medium Enterprises (SMEs) |
Competitive Landscape and Market Positioning
Prominent players in the data monetization in healthcare market:
1. Oracle Corporation (United States)
2. Microsoft Corporation (United States)
3. Google LLC (United States)
4. IQVIA Inc. (United States)
5. Optum Inc. (United States)
6. Palantir Technologies Inc. (United States)
7. SAS Institute Inc. (United States)
8. Snowflake Inc. (United States)
9. Health Catalyst Inc. (United States)
10. Flatiron Health Inc. (United States)
The data monetization in healthcare market is evolving rapidly through the integration of advanced analytics, interoperable data systems, and AI-driven decision platforms. Organizations are focusing on improving data accessibility and value extraction to support clinical efficiency, predictive healthcare insights, and operational optimization. Expansion of connected healthcare ecosystems and secure data-sharing frameworks is also driving innovation in personalized care and population health management.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Oracle Corporation (United States) | |||||||
| Microsoft Corporation (United States) | |||||||
| Google LLC (United States) | |||||||
| IQVIA Inc. (United States) | |||||||
| Optum Inc. (United States) | |||||||
| Palantir Technologies Inc. (United States) | |||||||
| SAS Institute Inc. (United States) | |||||||
| Snowflake Inc. (United States) | |||||||
| Health Catalyst Inc. (United States) | |||||||
| Flatiron Health Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Regeneron | May-25 | Regeneron successfully acquired the genetic database and research assets of 23andMe for USD 256 million. This acquisition allows the company to integrate vast repositories of genomic data into its R&D pipeline, providing a strategic advantage in identifying novel drug targets and advancing precision medicine through large-scale, population-based genetic research. |
| Oracle | May-25 | Oracle Health, Cleveland Clinic, and G42 formed a strategic partnership to launch an AI-driven global healthcare delivery platform. The initiative leverages Oracle’s cloud infrastructure and G42’s sovereign AI capabilities to create a scalable ecosystem for clinical data analytics, enabling healthcare providers and researchers to utilize real-world data for improved clinical trial enrollment and diagnostic accuracy. |
| Microsoft | Mar-25 | Microsoft collaborated with Kyndryl to launch Dragon Copilot, a generative AI-powered clinical assistant. By integrating voice-to-text and ambient listening capabilities directly into electronic health record workflows, the solution automates clinical documentation and evidence summarization. This development addresses administrative inefficiencies and enhances the value and usability of clinical data within health system operations. |
| Nvidia | Jan-25 | Nvidia expanded its healthcare AI ecosystem through partnerships with Mayo Clinic, IQVIA, Illumina, and the Arc Institute. By deploying DGX Blackwell systems and BioNeMo platforms, these entities are accelerating the development of specialized foundation models for genomics, digital pathology, and clinical trials, effectively scaling the monetization and utility of complex medical datasets. |
| Selfii | Jan-25 | Selfii launched the TripleBlind Exchange, a marketplace platform designed to facilitate secure, HIPAA/GDPR-compliant access to protected health information. The solution enables researchers and organizations to query patient data without requiring traditional de-identification or centralized data transfers, significantly lowering the regulatory and privacy barriers associated with health data monetization and collaborative research. |
| Atropos Health | Dec-24 | Atropos Health expanded its Evidence Network—a federated healthcare data ecosystem—by introducing AI model training capabilities. With access to over 200 million de-identified patient records, the platform provides pharmaceutical companies and health systems with a secure environment to develop and validate AI-driven insights, demonstrating the growing commercial demand for federated, research-ready health data. |
| Datma | Oct-24 | Datma introduced datma.FED, a two-sided federated marketplace for healthcare data. The platform allows health systems and labs to monetize their multi-omic and pathology datasets while retaining data control. By bypassing centralized storage, it offers pharmaceutical researchers scalable, high-quality, and compliant access to previously siloed real-world evidence, optimizing precision medicine and market access strategies. |
| Humana | Jul-24 | Humana entered a multi-year agreement with Google Cloud to modernize its cloud infrastructure and deploy generative AI capabilities. This initiative aims to harness Humana’s large-scale member and clinical datasets to improve operational efficiency, personalize member care, and reduce medical costs, representing a significant strategic investment in leveraging cloud-native data platforms for value-based healthcare. |
| Salesforce | Apr-23 | Salesforce launched the Customer 360 for Health suite, incorporating AI and real-time data automation to unify patient profiles. This initiative enhances the ability of healthcare organizations to aggregate data across various touchpoints, streamline patient engagement, and reduce administrative costs, directly supporting the broader industry shift toward data-driven, personalized clinical and operational management. |
| Redox | Feb-23 | Redox partnered with Google Cloud to replicate its healthcare data exchange platform on Google's cloud infrastructure. By simplifying the interoperability of clinical data across disparate systems, this collaboration enables faster, more secure access to healthcare information, facilitating more informed decision-making and AI model development for providers and technology developers alike. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Data Monetization in Healthcare Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Data Source | Clinical Data, Claims and Administrative Data, Patient-generated Data, Research and Genomic Data, Operational and Financial Data |
| Deployment Model | Cloud-based, On-premises, Hybrid |
| Data Ownership | Provider-owned Data, Payer-owned Data, Pharmaceutical and Biotechnology-owned Data, Patient-controlled Data, Public and Consortium Data |
Data Monetization in Healthcare Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Healthcare Data Commercialization Strategy |
|
| Healthcare Data Partnership Ecosystem |
|
| AI-Driven Data Monetization Opportunities |
|
Need a different cut of the data?
Request Custom ResearchHow much is the data monetization in healthcare market worth?
How is the data monetization in healthcare industry projected to perform over the next decade?
How is AI expanding commercial opportunities in the data monetization in healthcare market?
Why is pharmaceutical demand for real-world evidence accelerating healthcare data monetization?
Which method segment holds the largest share of the data monetization in healthcare market?
Why are medical technology companies the fastest-growing end-user segment in the data monetization in healthcare market?
Why does North America lead the data monetization in healthcare market?
What is driving fastest growth in Asia Pacific healthcare data monetization market?
What are the key competitors in the data monetization in healthcare landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization